Literature DB >> 31585126

A multivariate prediction model for high malignancy potential gastric GI stromal tumors before endoscopic resection.

Ze Yang1, Yuan Gao2, Xiaotong Fan1, Xin Zhao1, Shaohua Zhu1, Meng Guo1, Zhiguo Liu1, Xiaocui Yang2, Ying Han1.   

Abstract

BACKGROUND AND AIMS: Endoscopic resection is becoming an option in the management of gastric GI stromal tumors (GISTs). Although no consensus has been reached, patients with high malignancy potential GISTs are generally considered to be surgical candidates. However, no systematic preoperative evaluation strategy has yet been developed. The current study was performed to develop a preoperative multivariate model to predict the malignant potential of gastric GISTs.
METHODS: This study consisted of 2 stages. First, a multivariate prediction model for gastric GISTs smaller than 5 cm was developed using a multivariate logistic regression analysis in a retrospective cohort. Next, the prediction model was validated further in a validation cohort of gastric GISTs.
RESULTS: In the developing stage, 275 patients were included. The multivariate analysis demonstrated that independent risk factors for high malignancy potential gastric GISTs smaller than 5 cm were tumor size ≥2 cm (according to cutoff value), an irregular tumor shape, and mucosal ulceration (P < .05). Based on accordant regression coefficients, 3 risk factors were weighted with point values: 1 point for mucosal ulceration, 2 points for an irregular tumor shape, and 3 points for tumor size ≥2 cm. In the validation stage, 186 patients were included. The area under the curve of the prediction model was .80 (95% confidence interval, .73-.85), which was significantly higher than that of tumor size alone (P = .034).
CONCLUSIONS: The independent risk factors for high malignancy potential gastric GISTs smaller than 5 cm were tumor size larger than 2 cm, an irregular tumor shape, and mucosal ulceration. These factors could be used to predict malignancy potential of gastric GISTs in a simple combination.
Copyright © 2020 American Society for Gastrointestinal Endoscopy. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2019        PMID: 31585126     DOI: 10.1016/j.gie.2019.09.032

Source DB:  PubMed          Journal:  Gastrointest Endosc        ISSN: 0016-5107            Impact factor:   9.427


  5 in total

1.  A validated survival nomogram for early-onset diffuse gastric cancer.

Authors:  Fei Liao; Xufeng Guo; Xiaohong Lu; Weiguo Dong
Journal:  Aging (Albany NY)       Date:  2020-07-08       Impact factor: 5.682

2.  Surgical Resection Is Still Better Than Endoscopic Resection for Patients With 2-5 cm Gastric Gastrointestinal Stromal Tumours: A Propensity Score Matching Analysis.

Authors:  Hao Wu; Han Li; Qinfeng Xu; Liang Shang; Ronghua Zhang; Chen Li; Mengdi Fu; Wandi Xu; Jianfeng Chen; Jin Liu; Leping Li
Journal:  Front Oncol       Date:  2021-09-15       Impact factor: 6.244

3.  Gastrointestinal stromal tumors diagnosis on multi-center endoscopic ultrasound images using multi-scale image normalization and transfer learning.

Authors:  Chengcheng Liu; Yi Guo; Fei Jiang; Leiming Xu; Feng Shen; Zhendong Jin; Yuanyuan Wang
Journal:  Technol Health Care       Date:  2022       Impact factor: 1.205

4.  Prognostic nomograms for lung neuroendocrine carcinomas based on lymph node ratio: a SEER database analysis.

Authors:  Lan Xiong; Youfan Jiang; Tianyang Hu
Journal:  J Int Med Res       Date:  2022-09       Impact factor: 1.573

5.  Development and validation of a novel scoring system developed from a nomogram to identify malignant pleural effusion.

Authors:  Sufei Wang; Shan Tian; Yuan Li; Na Zhan; Yingyun Guo; Yu Liu; Juanjuan Xu; Yanling Ma; Shujing Zhang; Siwei Song; Wei Geng; Hui Xia; Pei Ma; Xuan Wang; Tingting Liao; Yanran Duan; Yang Jin; Weiguo Dong
Journal:  EBioMedicine       Date:  2020-07-30       Impact factor: 8.143

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.